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Information transfer in the brain requires a homeostatic control of neuronal excitability. Therefore, a functional balance between excitatory 
and inhibitory systems is established during development. This review contains recent information about the molecular mechanisms 
orchestrating the establishment and maintenance of this excitation-inhibition (E-I) balance, and it reviews examples of deregulation of 
inhibitory and excitatory systems at a molecular, network and disease level of investigation.
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INTRODUCTION
By keeping the neuronal fi ring rate within a narrow range, homeostatic 
plasticity provides a dynamic basis for adequate information transfer in 
the brain (Turrigiano and Nelson, 2000). To this end, a functional balance 
between excitatory and inhibitory synapses (E-I balance; Figure 1A) 
is established during development and maintained throughout life 
(Turrigiano and Nelson, 2004). Excitatory synaptic transmission is driven 
mainly by glutamatergic synapses whereas inhibitory synaptic trans-
mission involves GABAergic and glycinergic signaling. In addition to 
such synaptic working mode of neurons, tonic ion conductances play 
an important role in controlling overall neuronal excitability (Mody and 
Pearce, 2004). Together, these systems provide the spatial and temporal 
framework for physiological information transfer in the brain. Because 
deregulation of the E-I balance is frequently associated with a number 
of nervous system disorders, such as epilepsy, mental retardation and 
autism, this topic gains infl uence in both fundamental and clinical 
research.
E-I BALANCE AT THE LEVEL OF SYNAPSES 
AND OF THE NEURONAL NETWORK
Information transfer in the brain requires a constancy of the internal 
 environment, originally specifi ed by the American physiologist Walter 
Bradford Cannon (1932). Today, it is known that neuronal activity  controls 
itself in order to avoid runaway excitation or quiescence (Turrigiano and 
Nelson, 2004). For this purpose, a neuron has to establish mechanisms that 
not only provide neurons with a basic confi guration of synaptic inputs, but 
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also allow approximation of a homeostatic setpoint value of the E-I ratio of 
synaptic input in response to alterations in neuronal activity. Individual syn-
apses within such a basic confi guration can then be weighted  differently 
according to their potential to coincide with the neuronal output. Because 
setpoint approximation requires intracellular signaling and engages enzy-
matic processes it is expected to always lag behind sudden changes in 
neuronal activity, which therefore may generate vulnerable periods.
Plasticity at the level of individual synapses
Apart from alterations in presynaptic transmitter release, which has 
already been reviewed before (for review see Nicoll and Schmitz, 2005), 
synaptic plasticity directly involves lateral mobility of surface neurotrans-
mitter receptors. That neurotransmitter receptors diffuse laterally in the 
plane of the neuronal plasma membrane was recently exemplifi ed with 
glycine receptors (Meier et al., 2001). This study contributed to the concept 
of reversible postsynaptic neurotransmitter receptor anchoring that forms 
the basis of a dynamic equilibrium between highly mobile, non-synaptic 
and less mobile, postsynaptic receptors. This mechanism contributes to 
the determination of the ratio between non-synaptic and postsynaptic 
receptors at a given time. Several publications then showed that other 
neurotransmitter receptors, such as GABAA receptors (Bogdanov et al., 
2006) and ionotropic glutamate receptors (Borgdorff and Choquet, 2002), 
are also mobile within the neuronal plasma membrane, providing a basis 
for dynamic activity-dependent regulation of postsynaptic receptor num-
bers. In fact, recent data show that the number of postsynaptic ionotropic 
glutamate receptors is regulated by synaptic usage. The elegant experi-
ments conducted by Ehlers et al. (2007) disclosed that enrichment of 
postsynaptic domains with AMPA-type glutamate receptors is facilitated 
by activation of glutamatergic fi bers. As a result of glutamate receptor 
activation, postsynaptic Ca2+ transients slow down receptor diffusion, 
according to the degree of synaptic usage (Borgdorff and Choquet, 2002). 
This self-organizing system ensures that a suffi cient number of recep-
tors reside at postsynaptic domains, capable of appropriately answering 
presynaptic glutamate release. As receptor diffusion infl uences postsyn-
aptic receptor numbers on a time scale of minutes, postsynaptic respon-
siveness may change very rapidly. Thereby, the temporal coincidence of 
synapse usage with adjacent depolarizing currents or with the respective 
neuronal output operates as a setpoint device for postsynaptic receptor 
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numbers (Bi and Poo, 1998), and if sustained, ultimately assigns different 
weights to different synapses by long-term potentiation or depression 
(Malinow and Malenka, 2002).
A number of other regulatory mechanisms were identifi ed to contribute 
to differential weighting of individual synapses. For example, endocannab-
inoids were shown to locally increase the E-I ratio in response to repeti-
tive activation of glutamatergic fi bers, a phenomenon originally termed 
depolarization-induced suppression of inhibition (Freund et al., 2003). 
Thereby, increased E-I ratios are generated locally (Figure 1B) by  inducing 
long-term depression at neighboring GABAergic synapses via retrograde 
endocannabinoid signaling (Chevaleyre and Castillo, 2004). This mecha-
nism facilitates induction of long-term potentiation of glutamatergic 
 synapses adjacent to the depressed GABAergic input.
Altogether, synaptic plasticity mechanisms ensure local fi netuning 
of individual synapses for weighted information transfer from neuron to 
neuron and stimulus-appropriate information processing in the brain.
Plasticity at the neuronal level – delayed setpoint approximation
In 1994 already, Ger Ramakers noticed that homeostatic regulation 
increases the E-I ratio of synaptic input in response to chronic  neuron 
silencing (Ramakers et al., 1994). In fact, a large number of studies 
employing pharmacological modulation of neuronal activity showed that 
homeostatic mechanisms adjust the neuronal fi ring rate in response 
to altered neuronal activity. For example, prolonged pharmacological 
inactivation of ionotropic glutamate receptors or tetrodotoxin (TTX)-
 sensitive sodium channels evokes compensatory, homeostatic, mecha-
nisms orchestrating an up-scaling of the glutamatergic system, which 
prevents neuronal quiescence as long as neurons are silenced (Ramakers 
et al., 1990).
Per defi nition, homeostatic regulation is bidirectional. In this respect, 
it is conceivable that pharmacological blockade of GABAA receptors, 
which increases the neuronal output, engages homeostatic mechanisms 
in order to rectify the experimentally induced deviation from the setpoint 
of homeostasis. In fact, the neuron ends up with a down-scaled fi ring rate 
that prevents runaway excitation as long as GABAA receptors are blocked 
(Corner and Ramakers, 1992).
These experimentally determined homeostatic rules are in step with 
actual practice where intrinsic factors temporarily interfere with home-
ostasis. For example, progesterone potentiates GABAergic transmission 
during the menstrual cycle, which temporarily deviates the neuronal 
output from the setpoint of homeostasis and therefore elicits homeo-
static counter-regulation, i.e., down-scaling of inhibitory systems. A sud-
den fall of progesterone levels at the end of the menstrual cycle then 
increases seizure susceptibility in individuals with pre-existing epilep-
tic foci (Herzog, 1999; Klein and Herzog, 1998; Smith, 2001). Likewise, 
chronic ethanol consumption provokes homeostatic down-scaling of the 
ethanol-potentiated GABAergic system, and sudden ethanol withdrawal 
from these individuals lowers their seizure threshold (Cagetti et al., 
2004; Kokka et al., 1993). This indicates that the ethanol-driven homeo-
statically down-scaled GABAergic system alone no longer is capable of 
adequately balancing neuronal excitation. As setpoint approximation lags 
behind sudden alterations in neuronal activity vulnerable periods inevi-
tably  follow because neurons may become hyperexcitable and generate 
rebound activity.
A new hotspot for homeostatic regulation at the neuronal level
By scrutinizing hippocampal glycine receptors we identifi ed a novel 
potential mechanism that may contribute to homeostatic setpoint approx-
imation in response to hyperexcitability. So far, hippocampal glycine 
receptors were enigmatic: On the one hand they do not contribute to hip-
pocampal synaptic transmission (Bedet et al., 2006; Meier and Grantyn, 
2004; Song et al., 2006; Zhang et al., 2008) and on the other hand they 
may not even contribute to tonic hippocampal inhibition because their 
affi nity for glycine (Legendre, 2001) is far below hippocampal ambient 
glycine (Sherwin, 1999).
Yet, these receptors are expressed and synthesized in hippocampal 
neurons. However, a reconcilement of this discrepancy recently emerged 
from the discovery of high affi nity glycine receptor (haGlyR) variants 
(Meier et al., 2005). It was shown that haGlyRs are generated by post-
transcriptional, activity-dependent C-to-U RNA editing. Because their 
affi nity for glycine approximates hippocampal ambient glycine, these 
gain-of-function receptors are very well adapted to translate the ambient 
glycine and taurine concentrations in the hippocampus into tonic inhi-
bition of neuron fi ring, which may play a homeostatic role in cases of 
hyperexcitability. Further studies are necessary to determine a specifi c 
role for haGlyRs in hyperexcitability cases.
DEVELOPMENTAL INTERPRETATION 
OF HOMEOSTATIC REGULATION
According to the developmental state of neurons homeostatic regulation 
may have a completely different impact on the neuronal network. In the 
developing brain GABAergic transmission is still excitatory due to reduced 
expression of the potassium chloride co-transporter 2 (KCC2) (Rivera 
et al., 1999). In that condition chronic neuron silencing is  detrimental 
because the E-I balance is going to be established, and this requires 
activity-dependent functional adjustment of developing glutamatergic and 
GABAergic synapses. If prohibited through neuron silencing, GABAergic 
Figure 1. Local and global regulation of the E-I balance. (A) Starting 
point: homeostatically established E-I ratio of synaptic inputs to mature 
neurons with KCC2. (B) Local regulation: The E-I ratio of synaptic input 
can locally be enhanced to facilitate long-term potentiation of glutama-
tergic synapses (green). This strengthens glutamatergic inputs (blue) that 
temporally coincide with the neuronal output (blue arrow). Among others, 
endocannobinoids were identifi ed as retrograde messengers involved in 
functional suppression of GABAergic synapses (red) in the neighborhood 
of potentiated glutamatergic terminals. (C, D) Global regulation. (C) Early in 
development or in the epileptic brain, where KCC2 expression is low, weak-
ening or suppression of neuronal fi ring (silencing) provokes up-scaling of 
the glutamatergic system and down-scaling of the GABAergic system and, 
fi nally, elimination of silenced neurons through excitotoxic mechanisms. (D) 
In contrast, in the mature nervous  system, neuron silencing provokes con-
comitant up-scaling of both, GABAergic and glutamatergic systems, which 
homeostatically compensates for reduced neuronal output while keeping 
the E-I balance.
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synapses are down-scaled according to the  proposed default  elimination 
pathway for “un-synchronizable” GABAergic synapses (Tao and Poo, 
2005), and neurons that appear not to fi t into the developing network 
will ultimately be eliminated (Figure 1C; Eichler et al., unpublished). This 
rule may also apply to the epileptic brain, where neuronal hypoactivity 
occurs (Sloviter et al., 2006) and which was found to adopt an earlier 
developmental status in terms of KCC2 down-regulation and associ-
ated impairment of Cl− extrusion (Hartmann et al., 2001; Rivera et al., 
2002; Wake et al., 2007). By contrast, in the adult neuronal tissue, neuron 
silencing provokes concomitant up-regulation of both glutamatergic and 
GABAergic synapses (Figure 1D), which maintains the E-I ratio of syn-
aptic input (Burrone et al., 2002). Although exaggerated BDNF-signaling 
might be involved (Rivera et al., 2004; Singh et al., 2006), the identity of 
the molecular machinery responsible for such differential homeostatic 
regulation still has to be  disclosed. In conclusion, the capacity of neu-
rons to dynamically adjust the E-I ratio of synaptic input in response to 
alterations in neuronal activity certainly provides a homeostatic basis for 
information transfer in the adult brain. However, earlier in development as 
well as in the epileptic brain, alterations in neuronal activity are differently 
interpreted by the homeostatic machinery because, at that time, a physi-
ologically meaningful  neuronal integration into the developing network 
has to be set up.
SMALL MOLECULES, BIG IMPACT
On the way to mature synapses, appropriate expression and targeting of 
synapse-scaffolding molecules is required for the establishment, regula-
tion and maintenance of the E-I balance. In the following, some molecular 
key players involved in these processes will be discussed.
Cell adhesion molecules neuroligin-1 and -2
At a molecular level, excitatory and inhibitory synapses can be  dissected 
according to their postsynaptic enrichment of neuroligin-1 and -2 
(Chih et al., 2005; Craig and Kang, 2007). In excitatory glutamater-
gic synapses neuroligin-1 provides a physical link between pre- and 
postsynaptic membranes and thereby ensures transmitter-specifi c 
apposition of pre- and postsynaptic protein scaffolds (Fu et al., 2003). 
Correspondingly, neuroligin-2 links pre- and postsynaptic compart-
ments at inhibitory GABAergic synapses (Varoqueaux et al., 2004). As the 
expression of neuroligins and their presynaptic counterpart neurexin suf-
fi ces to induce the respective molecular scaffolds in fi broblast cells (Graf 
et al., 2004; Scheiffele et al., 2000) alterations in the expression and/or 
targeting of these cell adhesion molecules are expected to signifi cantly 
affect the E-I balance. As preformed scaffold protein packages are post-
synaptic hotspots for the formation of excitatory synapses (Gerrow et al., 
2006), it certainly is not surprising that overexpression of neuroligin-1 
and the scaffolding protein PSD-95 enhances the E-I ratio of synaptic 
input (Prange et al., 2004).
Scaffolding proteins
Postsynaptic domains of excitatory synapses contain a multitude of 
 different proteins, and there is substantial evidence that highlights 
the fundamental role of appropriate expression and targeting of scaf-
folding proteins during excitatory synapse formation and maintenance 
(El-Husseini et al., 2000). Actually, neuronal overexpression of PSD-95 
alone is suffi cient to enhance the ratio between glutamatergic and 
GABAergic synapses (Prange et al., 2004). Likewise, knockdown of 
PSD-95 results in partial loss of excitatory synapses, which decreases 
the E-I ratio of synaptic input (Prange et al., 2004). As PSD-95 cou-
ples NMDA-type glutamate receptors to complex signaling pathways 
that control bidirectional synaptic plasticity these fi ndings have direct 
implications for learning and memory (Lau and Zukin, 2007; Migaud 
et al., 1998).
It is tempting to speculate that other scaffolding proteins exert simi-
lar effects on the E-I ratio of synaptic input. Indeed, acute knockdown 
of SAP-97 diminishes excitatory synapse transmission and postsynaptic 
glutamate receptor clustering (Nakagawa et al., 2004). As these scaffold-
ing proteins provide protein–protein interaction platforms at excitatory 
synapses other constituents of these postsynaptic domains are expected 
to follow their rules. For example, targeting of guanylate kinase domain-
associated protein (GKAP) and AMPA-type glutamate receptors are 
dependent on the availability of PSD-95 (El-Husseini et al., 2000; Gerrow 
et al., 2006).
As the total number of synapses remains constant, a shift of the E-I 
balance apparently always occurs at the expense of one type of syn-
apse (Lardi-Studler et al., 2007; Prange et al., 2004), suggesting that 
glutamatergic and GABAergic synapses are co-regulated. Therefore, it is 
reasonable to assume that alterations in the expression and/or targeting 
of gephyrin, a scaffolding molecule of glycinergic and GABAergic postsy-
naptic domains, infl uence the E-I ratio of synaptic input. In line with this 
assumption, overexpression of gephyrin was found to decrease the E-I 
ratio (Lardi-Studler et al., 2007). Also, post-transcriptional mechanisms 
were identifi ed that could be relevant for the control of the E-I ratio of 
synaptic input: The recently identifi ed C5-gephyrin splice variant (Meier 
et al., 2000) was shown not only to be capable of controlling glycine 
receptor surface stability, but also to exert dominant negative effects on 
postsynaptic gephyrin (Bedet et al., 2006). Whether the expression of 
C5-gephyrins thereby affects the E-I ratio remains to be determined. In 
conclusion, appropriate expression and targeting of scaffolding proteins 
contribute to the control of the E-I ratio of synaptic input.
HUMAN DISEASES AFFLICTED 
WITH DEREGULATION OF E-I BALANCE
Deregulation of the E-I ratio of synaptic input has been associated with 
a variety of human nervous system disorders. In the following, potential 
coherences between deregulated E-I ratios and the phenomenology of 
nervous system disorders will be discussed.
Increased E-I ratios of synaptic input
In epilepsy patients a multitude of genes can be affl icted with genomic 
loss- or gain-of-function mutations, which generates a persistent devia-
tion of the neuronal output from the setpoint of homeostasis. For exam-
ple, epilepsy-associated mutations were found in GABA(A) receptor 
(GABRG2), sodium (SCN1, SCN2), potassium (KCNA, KCNQ) and calcium 
channel (CACNA1A) genes (Kullmann, 2002; Scheffer and Berkovic, 2003; 
Sloviter, 1987). Although it is known that increased E-I ratios of synaptic 
input accompany the phenomenology of epilepsy, it remains to be elu-
cidated whether this is causative for the disease or whether it occurs 
secondarily to pathological patterns of enhanced synchronous neuronal 
network activity (Kofke et al., 1997; Stief et al., 2007).
Decreased E-I ratios of synaptic input
Decreased E-I ratios of synaptic input are associated with nervous 
 system disorders, and recent fi ndings underscore the relevance of func-
tional cell adhesion systems in nervous system physiology. For example, 
loss-of-function mutations in genes encoding neuroligin (NLGN-3 and 
NLGN-4 ) and β-neurexin (NRXN1) were implicated in autism and men-
tal retardation (Feng et al., 2006; Jamain et al., 2003; Laumonnier et al., 
2004). Interestingly, a loss-of-function mutation in the scaffolding protein 
and neuroligin binding partner SHANK3 could also be related to autism 
(Durand et al., 2007). Likewise, interference with PSD-95 protein synthe-
sis through deletion of the fragile X mental retardation protein (FMRP ) 
gene causes mental retardation (Todd et al., 2003). Finally, decreased 
E-I ratios of synaptic input were associated with Rett Syndrome, a per-
vasive neurodevelopmental disorder associated with mental retardation 
and autistic behavior. In this case, however, decreased E-I ratios result 
from loss-of-function mutations of the MECP2 gene, which encodes 
a methyl CpG-binding protein potentially involved in global repression 
of  transcription (Dani et al., 2005). Altogether, it seems as if one could 
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reduce these diverse genetic origins of mental retardation and autism to 
a common denominator, which could be the neuronal failure to establish 
an adequate connectivity with glutamatergic neurons.
The AMPA-to-NMDA receptor ratio
At glutamatergic synapses, the ratio between AMPA- and NMDA-type gluta-
mate receptors determines the postsynaptic responsiveness to presynaptic 
glutamate release: Decreased postsynaptic AMPA-to-NMDA receptor ratios 
reduce the threshold for LTP-induction and synaptic plasticity, but may gen-
erate silent synapses if AMPA-receptors disappear completely. Likewise, 
increased postsynaptic AMPA-to-NMDA receptor ratios ensure basal synap-
tic transmission at the expense of synaptic plasticity. For example, increased 
AMPA-to-NMDA receptor ratios were found in patients affl icted with 
Alzheimer’s disease (Snyder et al., 2005) and schizophrenia (Mohn et al., 
1999). Therefore, subtle changes in the neurotransmitter receptor compo-
sition of postsynaptic densities may directly contribute to pathophysiologi-
cal mechanisms involved in nervous system disorders, without necessarily 
affecting the morphologically determined E-I ratio of synaptic input.
Critical role for neurotransmitter transporters
As afore mentioned, purely morphological criteria are not suffi cient to 
draw conclusions at a functional level. In that respect, it is important to 
note that the level of ambient neurotransmitters critically depends on 
re-uptake mechanisms, which includes both a steady clearance of the 
extracellular space as well as removal of presynaptically released neuro-
transmitters. For example, impairment of glycine re-uptake by glial cells 
(GlyT-1, steady clearance) and by neurons (GlyT-2, presynaptic clearance) 
generates  defi cits in respiration (Gomeza et al., 2003a) and provokes 
hyperexcitability (Gomeza et al., 2003b; Rees et al., 2006), respectively. 
Moreover, glycine as a co-agonist at NMDA-type glutamate receptors criti-
cally infl uences NMDA-receptor responsiveness. Therefore, disruption of 
the glial glycine transporter GlyT-1 in the forebrain clearly compensates 
for NMDA-receptor hypofunctionality in a disease model of schizophrenia 
(Yee et al., 2006). In addition, loss-of-function mutations in the GlyT-1 gene 
(SLC6A9) were uncovered to cause glycine encephalopathy by enhancing 
tonic glycine receptor activation, as a result of defi cits in the glial glycine 
uptake system (Applegarth and Toone, 2001). Likewise, as reviewed previ-
ously (Dalby, 2003; Schousboe, 2003), GABA and glutamate transporters 
are essential for physiological neuronal information transfer.
OUTLOOK
The brain works appropriately only if all molecular constituents (among 
others: receptors, neurotransmitters, synapses, neurons) are prop-
erly assembled and installed, which actually establishes a functional 
syncytium of the brain. However, there is an overwhelming number of 
laboratories and studies investigating items of this functional syncy-
tium separately. Although a signifi cant and increasing number of studies 
point to multiple interrelations between homeostatic glutamatergic and 
GABAergic mechanisms still little is known about the molecular identity 
of the heterosynaptic plasticity machinery and their reference to nervous 
system disorders. Therefore, future experimental approaches should give 
consideration to such interrelation between excitatory and inhibitory sys-
tems in the brain, which may open avenues in the treatment of nervous 
system disorders affl icted with a deregulated E-I balance.
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